Jay R. Venkatesan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jay R. Venkatesan
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jay R. Venkatesan

Form 4 holding Director, 10%+ Owner

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
2,600,980
Estimated value
$33,136,485
Report date
15 Jul 2022
Price
$12.74
Ownership
By Alpine ImmunoSciences, L.P.
Form 4 holding Director, 10%+ Owner

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
238,126
Estimated value
$3,033,725
Report date
15 Jul 2022
Price
$12.74
Ownership
Direct
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
96,525
Estimated value
$500,000
Report date
08 Apr 2025
Price
$5.18
Ownership
The Jay Venkatesan Legacy Trust
Underlying class
Common Stock, $0.0001 par value
Underlying amount
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Pre-Funded Warrants
Shares / value
50,000
Estimated value
$249,500
Report date
28 Jun 2024
Price
$4.99
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
18,633
Estimated value
$237,384
Report date
15 Jul 2022
Price
$12.74
Ownership
By Raj Venkatesan as UTMA custodian for Nathaniel Graham Venkatesan
Form 4 holding Director, 10%+ Owner

ALPINE IMMUNE SCIENCES, INC.

Security class
Common Stock
Shares / value
18,633
Estimated value
$237,384
Report date
15 Jul 2022
Price
$12.74
Ownership
By Raj Venkatesan as UTMA custodian for Reid Coleman Venkatesan
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Common Stock
Shares / value
179,581
Estimated value
$1,796
Report date
26 Nov 2024
Price
$0.0100
Ownership
Direct
Form 4 holding Director, 10%+ Owner

ALPINE IMMUNE SCIENCES, INC.

Security class
Stock Option (Right to buy)
Shares / value
70,000
Estimated value
Report date
15 Jul 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Common Warrants
Shares / value
50,000
Estimated value
Report date
28 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
10,000
Estimated value
Report date
07 Nov 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Elicio Therapeutics, Inc.

Security class
Warrant to Purchase Common Stock
Shares / value
0
Estimated value
Report date
26 Nov 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jay R. Venkatesan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .